CATTABRIGA, Elena
 Distribuzione geografica
Continente #
NA - Nord America 2.828
EU - Europa 763
AS - Asia 624
OC - Oceania 1
SA - Sud America 1
Totale 4.217
Nazione #
US - Stati Uniti d'America 2.826
CN - Cina 363
UA - Ucraina 226
DE - Germania 218
TR - Turchia 149
SG - Singapore 95
GB - Regno Unito 87
SE - Svezia 65
IT - Italia 61
FI - Finlandia 46
RU - Federazione Russa 26
NL - Olanda 13
FR - Francia 12
HK - Hong Kong 8
BE - Belgio 5
IN - India 4
CA - Canada 2
CZ - Repubblica Ceca 2
AU - Australia 1
BD - Bangladesh 1
BO - Bolivia 1
IE - Irlanda 1
IM - Isola di Man 1
IQ - Iraq 1
KR - Corea 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 4.217
Città #
Woodbridge 346
Fairfield 315
Houston 271
Chandler 270
Jacksonville 247
Ann Arbor 210
Ashburn 160
Seattle 127
Wilmington 105
Nanjing 95
Cambridge 92
Beijing 75
Izmir 71
Singapore 66
Princeton 56
Bremen 47
Boardman 43
New York 43
Milan 32
Shanghai 32
Dearborn 30
Addison 26
Los Angeles 22
San Diego 22
Nanchang 19
Shenyang 18
Hebei 17
Tianjin 15
San Mateo 14
Santa Clara 12
Changsha 11
Jinan 11
Auburn Hills 10
Jiaxing 9
Kunming 9
Meppel 9
Norwalk 9
Hong Kong 8
Ningbo 8
Philadelphia 8
Lanzhou 6
Brussels 5
Des Moines 5
Hefei 5
Mountain View 5
Orange 5
Redmond 5
Zhengzhou 5
Chicago 4
Fuzhou 4
Guangzhou 4
Hangzhou 4
Indiana 3
London 3
Pune 3
Sirignano 3
Washington 3
Edinburgh 2
Falls Church 2
Ferrara 2
Haikou 2
Monmouth Junction 2
Taizhou 2
Tappahannock 2
Verona 2
Amsterdam 1
Barwon 1
Brampton 1
Brno 1
Castelbellino 1
Changchun 1
Coventry 1
Crevalcore 1
Den Haag 1
Douglas 1
Dublin 1
Florence 1
Fort Lauderdale 1
Genoa 1
Glasgow 1
Helsinki 1
Jülich 1
Leawood 1
Marseille 1
Modena 1
Montreal 1
Munich 1
New Bedfont 1
Parma 1
Redwood City 1
Samarkand 1
Simi Valley 1
Sucre 1
Taipei 1
Taiyuan 1
Tampa 1
Wuhan 1
Zhongxin 1
Totale 3.111
Nome #
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 135
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 122
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 120
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 120
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 115
Synthesis, radiolabeling, and preliminary biological evaluation of [H-3]-1-[(S)-N,O-bis-(isoquinolinesulfonyl)-N-methyl-tyrosyl]-4-(o-tolyl )-piperazine, a potent antagonist radioligand for the P2X(7) receptor 115
A convenient synthesis by microwave heating and pharmacological evaluation of novel benzoyltriazole and saccharine derivatives as 5-HT(1A) receptor ligands 114
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 112
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 112
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 111
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 109
Synthesis by microwave irradiation and binding properties of novel 5-HT(1A) receptor ligands 109
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 109
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 107
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 107
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line 106
null 106
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 105
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 103
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 100
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 95
Differential expression of A3 adenosine receptors in colorectal cancer and related mucosa: a mirror in blood cells. 92
Aberrant A2A receptor function in peripheral blood cells in Huntington's disease 92
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 91
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 91
null 90
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 87
null 87
Expression and functionality of adenosine receptors in human blood cells 86
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 85
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 81
[3H]-MRE 2029-F20, A Novel Selective Antagonist Radiolig and, for the Pharmacological and Biochemical Characterization of A2B Receptors. 75
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 73
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 72
Expression and functional A3 adenosine receptors in human lymphocytes 69
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 69
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 69
Expression, pharmacological profile, and functional coupling of A(2B) receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [H-3]MRE 2029-F20 68
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils. 68
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 66
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 65
Expression of functional A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. 65
Effects of doxazosin and propranolol on A2A adenosine receptos of essential hypertensive patients 64
Pharmacological and biochemical characterization of A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells. 63
Aberrant A2A adenosine receptor function in peripheral blood cells of Huntington's disease patients and at risk mutation carriers. 60
Caffeine intake induces an alteration in human neutrophil A2A adenosine receptors 36
Adenosine Receptors in Colon Carcinoma Tissues and Colon Tumoral Cell Lines: Focus on the A3 Adenosine Subtype 28
Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. 24
Totale 4.248
Categoria #
all - tutte 15.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 273
Totale 16.248


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020722 0 0 20 119 54 112 75 94 83 98 54 13
2020/2021496 62 46 11 55 20 76 7 61 6 59 68 25
2021/2022477 9 51 36 16 13 17 10 16 19 37 56 197
2022/2023608 48 71 19 79 130 70 32 47 62 2 28 20
2023/2024259 24 22 9 7 33 65 7 10 8 4 15 55
2024/2025115 17 30 68 0 0 0 0 0 0 0 0 0
Totale 4.248